CYP2D6 genetic variations are associated with inter-individual variability in drug response, making it crucial to identify patients with altered CYP2D6 enzyme function. The Viennalab CYP2D6 PCR Kit covers the most clinically relevant loss-of-function, reduced function, and increased function alleles, including *3 – *8, *11, *12, *15, *40, *58, *9, *10, *14, *17, *29, *41, *1xN, *2xN, and *35xN (N=copy number). By referring to the clinical guidelines listed on PharmGKB, you can make informed drug prescribing recommendations and reduce the risk of adverse events or lowered treatment efficacy.

Approximately 6% of Europeans are poor metabolizers, 7% are intermediate metabolizers, and 3% are ultrarapid metabolizers. The PGX-CYP2D6 XL StripAssay® in combination with the CYP2D6 RealFastTM CNV Assay enables you to identify patients with altered CYP2D6 enzyme function, facilitating the choice of medication and/or adjustment of drug dosage. This, in turn, reduces the risk of adverse events or lowered treatment efficacy, ensuring the safety and well-being of your patients.

Don’t let CYP2D6 genetic variations compromise your patients’ drug response – invest in the Viennalab CYP2D6 PCR Kit today and take your personalized medicine approach to the next level!